Cargando…
Development of Actinobacillus pleuropneumoniae ApxI, ApxII, and ApxIII-specific ELISA methods for evaluation of vaccine efficiency
Among various vaccines against Actinobacillus pleuropneumoniae, subunit vaccines using recombinant proteins of ApxI, ApxII, and ApxIII as vaccine antigens have shown good efficacy in terms of safety and protection. Therefore, subunit vaccines are being applied worldwide and the development of new su...
Autores principales: | Jung, Myunghwan, Won, Hokeun, Shin, Min-Kyoung, Oh, Myung Whan, Shim, Soojin, Yoon, Injoong, Yoo, Han Sang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Veterinary Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6441810/ https://www.ncbi.nlm.nih.gov/pubmed/30944525 http://dx.doi.org/10.4142/jvs.2019.20.e2 |
Ejemplares similares
-
Porcine CD18 mediates Actinobacillus pleuropneumoniae ApxIII species-specific toxicity
por: Vanden Bergh, Philippe G.A.C., et al.
Publicado: (2009) -
Elucidating the role of ApxI in hemolysis and cellular damage by using a novel apxIA mutant of Actinobacillus pleuropneumoniae serotype 10
por: Chang, Nai-Yun, et al.
Publicado: (2014) -
Actinobacillus pleuropneumoniae exotoxin ApxI induces cell death via attenuation of FAK through LFA-1
por: Li, Siou-Cen, et al.
Publicado: (2021) -
Immunological study of an attenuated Salmonella Typhimurium
expressing ApxIA, ApxIIA, ApxIIIA and OmpA of Actinobacillus
pleuropneumoniae in a mouse model
por: HUR, Jin, et al.
Publicado: (2015) -
An in vitro study of ApxI from Actinobacillus pleuropneumoniae serotype 10 and induction of NLRP3 inflammasome‐dependent cell death
por: Hernandez‐Cuellar, Eduardo, et al.
Publicado: (2021)